Europe — EMA

Ondansetron B. Braun

Ondondansetron, the active ingredient in Ondansetron B. Braun, is a 5-HT3 receptor antagonist presented as an injection for intravenous use.

Ondansetron

Request sourcing

Pack/s

What is Ondansetron?

Ondondansetron, the active ingredient in Ondansetron B. Braun, is a 5-HT3 receptor antagonist presented as an injection for intravenous use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult and pediatric patients.

GNH USA supplies Ondansetron B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Ondansetron used for?

Ondansetron B. Braun is a selective 5‑HT3 receptor antagonist used in the management of nausea and vomiting pathways: - Chemotherapy‑induced nausea and vomiting: reduces both acute and delayed episodes. - Radiation‑induced nausea and vomiting: helps control symptoms during and after treatment. - Post‑operative nausea and vomiting: decreases the incidence of vomiting after surgery. - Hyper‑emesis gravidarum: provides relief when other therapies are insufficient. - Nausea due to gastro‑intestinal disorders: alleviond -

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →